Top

Infection

Published in:

16-02-2022 | Meningococcus | Brief Report

The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)

Authors: Marco Peradotto, A. Bondi, D. Lombardi, P. Bottino, E. Zanotto, A. M. Barbui, R. Cavallo

Published in: Infection | Issue 3/2022

Abstract

Purpose

The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy).

Methods

We defined the monthly incidence of S. pneumoniae, H. influenzae and N. meningitides-invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015–2019) and the monthly cases in 2020 or 2021.

Results

We found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae-invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children.

Conclusions

Further data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.

Pezzotti P, Bellino S, Riccardo F, Lucaroni F, Cerquetti M, Pantosti A, Rezza G, Stefanelli P. Vaccine preventable invasive bacterial diseases in Italy: a comparison between the national surveillance system and recorded hospitalizations, 2007–2016. Vaccine. 2019;37:41–8. https://doi.org/10.1016/j.vaccine.2018.11.047 (Epub 2018 Nov 23. PMID: 30478004).CrossRefPubMed

Chan KS, Liang FW, Tang HJ, Toh HS, Yu WL. Collateral benefits on other respiratory infections during fighting COVID-19. Med Clin (Barc). 2020;155:249–53. https://doi.org/10.1016/j.medcli.2020.05.026 (PMID: 32586667; PMCID: PMC7274613).CrossRef

Yun HE, Ryu BY, Choe YJ. Impact of social distancing on incidence of vaccine-preventable diseases. South Korea J Med Virol. 2021;93:1814–6. https://doi.org/10.1002/jmv.26614 (Epub 2020 Nov 1. PMID: 33079384).CrossRefPubMed

Servizio di riferimento Regionale di Epidemiologia per la sorveglianza, la prevenzione e il controllo delle Malattie Infettive (SEREMI). Malattie prevenibili da vaccino. SeREMI, 2021. https://www.seremi.it/sites/default/files/REPORT%20MABI%202020%20ed%202021.pdf

Stefanelli P, Fazio C, Vacca P, Neri A, Ambrosio L, Rezza G. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease? Pathog Glob Health. 2021. https://doi.org/10.1080/20477724.2021.1995657 (Epub ahead of print. PMID: 34844520).CrossRefPubMedPubMedCentral

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK, Rodriguez-Morales AJ. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28:174–84 (Ahead of print. PMID: 32275259).PubMed

Istituto Superiore di Sanità, Sorveglianza delle Malattie Batteriche Invasive in Italia. Rapporto Consolidato 2019. https://www.iss.it/sn-mbi-rapporti-iss

Taha MK, Deghmane AE. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes. 2020;13:399. https://doi.org/10.1186/s13104-020-05241-9 (PMID: 32854773; PMCID: PMC7450896).CrossRefPubMedPubMedCentral

Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard CL, Litt D, Fry NK, Andrews N, Ramsay ME, Ladhani SN. Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study. England Clin Infect Dis. 2021;72:e65–75. https://doi.org/10.1093/cid/ciaa1728 (PMID: 33196783; PMCID: PMC7717180).CrossRefPubMed

10.

Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285: 198005. https://doi.org/10.1016/j.virusres.2020.198005 (Epub 2020 May 11. PMID: 32408156; PMCID: PMC7213959).CrossRefPubMedPubMedCentral

11.

Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–75. https://doi.org/10.1016/j.jinf.2020.05.046 (Epub 2020 May 27. PMID: 32473235; PMCID: PMC7255350).CrossRefPubMedPubMedCentral

12.

Kitano T, Aoki H. A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: a dynamic transmission model in Japan. Vaccine. 2021;39:343–9. https://doi.org/10.1016/j.vaccine.2020.11.053 (Epub 2020 Nov 24 PMID: 33280853).CrossRefPubMed

Title: The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)
Authors: Marco Peradotto
A. Bondi
D. Lombardi
P. Bottino
E. Zanotto
A. M. Barbui
R. Cavallo
Publication date: 16-02-2022
Publisher: Springer Berlin Heidelberg
Keywords: Meningococcus
Pneumococcus
SARS-CoV-2
COVID-19
Published in: Infection / Issue 3/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-022-01770-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2022

Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases

Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission

Can microalbuminuria be an ındicator of renal ınvolvement in pediatric Covid 19 patients?

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases

Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials